AB InBev Named Olympics Games Partner
By Elena Vardon
Budweiser maker Anheuser-Busch InBev has been named as a partner of the Olympic Games, with its zero-alcohol beer Corona Cero chosen as the sporting event's global beer sponsor.
The brewer--which also houses Stella Artois and Hoegaarden among its portfolio--has been selected as a Worldwide Olympic Partner through 2028, the International Olympic Committee said Friday.
"We are proud to be the first beer sponsor for the Olympics at the Worldwide Olympic Partner level," AB InBev Chief Executive Michel Doukeris said.
The agreement also includes marketing rights for the International Paralympic Committee and the Paralympic Games, the committee said.
Last year, mixed-martial arts league UFC appointed InBev's Bud Light as its official beer in the U.S. and its official global beer partner.
Sales of Bud Light in North America plummeted in April after Dylan Mulvaney, a transgender social-media star, made an Instagram post about a personalized can of the beer that the brewer had sent her as a gift, prompting a boycott.
Write to Elena Vardon at elena.vardon@wsj.com
(END) Dow Jones Newswires
January 12, 2024 09:21 ET (14:21 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?
-
Mastercard Earnings: A Stable Environment Highlights the Firm’s Strengths
-
Pfizer Earnings: Solid Results Supported by Steady Tracking Toward $4 Billion In Cost Cuts
-
Starbucks Earnings: Not a Lot to Like About Results as Global Traffic Sputters